Minjie Fu

Title: Minjie Fu: Innovator in Genetic Engineering

Introduction

Minjie Fu is a prominent inventor based in Anhui, China. He has made significant contributions to the field of genetic engineering, particularly in the development of genetically engineered bacteria. His work focuses on enhancing the production of nicotinamide adenine dinucleotide (NAD), a crucial coenzyme in cellular metabolism.

Latest Patents

Minjie Fu holds a patent for a genetically engineered bacterium, which includes a method for its construction and application in producing NAD. The invention involves knocking out the gene encoding adenine deaminase in the bacterium's genome and integrating the gene encoding the enzyme in the NAD anabolic pathway. This innovative approach results in a strain with high NAD yield, showcasing Fu's expertise in genetic manipulation.

Career Highlights

Fu is currently associated with Hefei Knature Bio-pharm Co., Ltd., where he continues to advance his research in biotechnology. His work has garnered attention for its potential applications in pharmaceuticals and metabolic engineering. With a patent portfolio that includes 1 patent, Fu is recognized for his contributions to the scientific community.

Collaborations

Minjie Fu collaborates with notable colleagues, including Wei Wang and Kanglin Wang, who contribute to his research endeavors. Their combined expertise enhances the innovative projects at Hefei Knature Bio-pharm Co., Ltd.

Conclusion

Minjie Fu's work in genetic engineering exemplifies the potential of biotechnology to address critical challenges in health and medicine. His patented innovations pave the way for advancements in NAD production, highlighting the importance of research in this field.